Tether, the entity behind the renowned Tether stablecoin, recently underwent significant restructuring, culminating in a substantial investment move. On April 29, Tether revealed a strategic infusion of $200 million into Blackrock Neurotech, effectively securing a majority stake in the neural implant company.

Tether 是著名的 Tether 穩定幣背後的實體，最近進行了重大重組，最終促成了一項重大投資舉措。 4 月 29 日，Tether 宣布向 Blackrock Neurotech 策略注資 2 億美元，有效獲得了這家神經植入公司的多數股權。

This investment marked the inaugural venture of Tether Evo, a fresh division concentrating on the convergence of human potential and technology.

這項投資標誌著 Tether Evo 的首次創業，這是一個專注於人類潛力與科技融合的新部門。

Established in 2008, Blackrock Neurotech stands as a trailblazer in human brain-computer-interface (BCI) technology, renowned for its cutting-edge interfaces. The company is dedicated to aiding millions worldwide afflicted by paralysis and neurological disorders hindering basic functions.

Blackrock Neurotech 成立於 2008 年，是人腦電腦介面 (BCI) 技術的開拓者，以其尖端的介面而聞名。該公司致力於幫助全球數百萬人遭受癱瘓和妨礙基本功能的神經系統疾病的困擾。

Blackrock Neurotech’s groundbreaking brain interface technology has empowered patients to control robotic arms, navigate wheelchairs, communicate, browse the internet, and even drive vehicles using their thoughts. In a notable instance in 2016, patient Nathan Copeland made headlines by utilizing Blackrock BCI to interact with a robotic arm, culminating in a fist bump with then-U.S. President Barack Obama.

Blackrock Neurotech 的突破性大腦介面技術使患者能夠控制機械手臂、駕駛輪椅、交流、瀏覽互聯網，甚至用他們的思想駕駛車輛。 2016 年的一個值得注意的例子是，患者 Nathan Copeland 通過利用 Blackrock BCI 與機械臂互動而成為頭條新聞，最終與當時的美國總統擊拳。美國總統歐巴馬。

READ MORE: Dogecoin Leads Meme Coin Rally with 4.43% Increase in Value Over Past Month

閱讀更多：狗狗幣引領 Meme 幣漲勢，過去一個月價值上漲 4.43%

Tether’s $200 million investment aims to bolster the commercialization and implementation of medical solutions already benefiting over 40 individuals. Additionally, the investment will fuel advancements in research and development, ensuring Blackrock Neurotech remains a key player in the BCI landscape with a steadfast focus on human advancement.

Tether 的 2 億美元投資旨在促進已使 40 多人受益的醫療解決方案的商業化和實施。此外，這項投資將推動研發進步，確保 Blackrock Neurotech 始終成為 BCI 領域的關鍵參與者，堅定關注人類進步。

Paolo Ardoino, CEO of Tether, envisions Blackrock Neurotech as merely the inception of Tether Evo’s mission to champion projects that redefine technological boundaries in enhancing human potential. He stated, “Blackrock Neurotech represents a leap towards a future where technology not only complements but enhances our human experience, and we at Tether are proud to begin this journey with them.”

Tether 執行長 Paolo Ardoino 認為 Blackrock Neurotech 只是 Tether Evo 使命的開始，其使命是支持重新定義技術邊界以增強人類潛力的專案。他表示：“Blackrock Neurotech 代表了向未來的飛躍，技術不僅補充而且增強了我們的人類體驗，我們 Tether 很自豪能夠與他們一起開始這一旅程。”

Florian Solzbacher, co-founder of Blackrock Neurotech, emphasized the company’s long-term commitment to restoring functions in individuals, underscoring the necessity of dedicated and visionary partners. He expressed gratitude towards Tether, highlighting their shared vision in fostering technological innovations for the betterment of humanity.

Blackrock Neurotech 聯合創始人 Florian Solzbacher 強調了該公司對恢復個人功能的長期承諾，強調了敬業且富有遠見的合作夥伴的必要性。他對 Tether 表示感謝，強調了他們在促進技術創新以造福人類方面的共同願景。

This announcement follows Tether’s introduction of four new business divisions on April 18, signaling its diversified focus across Tether Data, Tether Finance, Tether Power, and Tether Edu.

在此公告之前，Tether 於 4 月 18 日推出了四個新的業務部門，標誌著其多元化業務重點涵蓋 Tether Data、Tether Finance、Tether Power 和 Tether Edu。

To submit a crypto press release (PR), send an email to sales@cryptointelligence.co.uk.

若要提交加密貨幣新聞稿 (PR)，請發送電子郵件至 sales@cryptointelligence.co.uk。